13F Filings History of BRAIDWELL LP

Latest 13F report
Q3 2025 - 14 Nov 2025
Value $
$3,370,348,920
Signature - Title
Ken Joseph - Chief Compliance Officer
Location
Stamford, CT
Summary
This page shows a list of all the recent 13F filings made by BRAIDWELL LP. Form 13F is required to be filed within 45 days of the end of a calendar quarter. BRAIDWELL LP reported 73 stock holdings with total value $3,370,348,920 as of Q3 2025. Top holdings included GUARDANT HEALTH INC, CAI, NOVOCURE LTD, XENE, and CGON.

Notify me when BRAIDWELL LP files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q3 2025 73 $3,370,348,920 +$737,465,023 -$575,050,783 +$162,414,240 GUARDANT HEALTH INC, CAI, NOVOCURE LTD, XENE, CGON 13F-HR 14 Nov 2025, 16:07
Q2 2025 55 $2,923,924,032 +$499,741,109 -$570,956,679 -$71,215,570 GUARDANT HEALTH INC, CAI, NBIX, NOVOCURE LTD, XENE 13F-HR 14 Aug 2025, 16:34
Q1 2025 64 $2,844,802,567 +$846,348,550 -$1,118,782,305 -$272,433,755 GUARDANT HEALTH INC, NOVOCURE LTD, NBIX, LEGN, REPLIGEN CORP 13F-HR 15 May 2025, 16:34
Q4 2024 73 $3,372,652,431 +$584,985,822 -$597,705,270 -$12,719,448 GUARDANT HEALTH INC, BRIDGEBIO PHARMA INC, NOVOCURE LTD, NBIX, REPLIGEN CORP 13F-HR 14 Feb 2025, 16:18
Q3 2024 81 $3,527,985,574 +$699,942,636 -$551,185,675 +$148,756,961 GUARDANT HEALTH INC, BRIDGEBIO PHARMA INC, NOVOCURE LTD, CGON, NUVASIVE INC 13F-HR 14 Nov 2024, 16:22
Q2 2024 75 $3,187,767,909 +$925,413,405 -$688,113,088 +$237,300,317 GUARDANT HEALTH INC, BRIDGEBIO PHARMA INC, NOVOCURE LTD, NUVASIVE INC, NBIX 13F-HR 14 Aug 2024, 16:29
Q1 2024 70 $3,102,773,641 +$917,098,241 -$612,267,221 +$304,831,020 GUARDANT HEALTH INC, BRIDGEBIO PHARMA INC, EXACT SCIENCES CORP, NOVOCURE LTD, APGE 13F-HR 15 May 2024, 16:26
Q4 2023 72 $2,722,670,757 +$374,961,295 -$1,014,613,338 -$639,652,043 GUARDANT HEALTH INC, BRIDGEBIO PHARMA INC, ASCENDIS PHARMA A/S, EXACT SCIENCES CORP, NOVOCURE LTD 13F-HR 14 Feb 2024, 16:37
Q3 2023 85 $3,164,360,709 +$710,756,067 -$423,382,214 +$287,373,853 GUARDANT HEALTH INC, NOVOCURE LTD, ASCENDIS PHARMA A/S, EXACT SCIENCES CORP, NANOSTRING TECHNOLOGIES INC 13F-HR 14 Nov 2023, 16:36
Q2 2023 81 $3,060,428,640 +$589,173,408 -$680,885,126 -$91,711,718 GUARDANT HEALTH INC, EXACT SCIENCES CORP, NOVOCURE LTD, NANOSTRING TECHNOLOGIES INC, ASCENDIS PHARMA A/S 13F-HR 14 Aug 2023, 16:29
Q1 2023 81 $2,924,706,963 +$463,204,594 -$495,570,711 -$32,366,117 GUARDANT HEALTH INC, EXACT SCIENCES CORP, NANOSTRING TECHNOLOGIES INC, NOVOCURE LTD, ALPHATEC HLDGS INC 13F-HR 15 May 2023, 17:18
Q4 2022 88 $2,946,459,579 $0 $0 $0 GUARDANT HEALTH INC, NANOSTRING TECHNOLOGIES INC, NOVOCURE LTD, EXACT SCIENCES CORP, ALPHATEC HLDGS INC 13F-HR 14 Feb 2023, 16:27